YOUR DAILY PEPTIDE BRIEFING / SCIENCE / COMMUNITYNew source checks every six hours
Daily Peptide StackNEWS • RESEARCH • COMMUNITY
THE NEWS STACK / SOURCE NOTE

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients.

A source-backed record from the peptide news monitor, with the original source linked below.

BEFORE YOU READ

This page links to the original record; it is not an independent analysis or clinical recommendation.

← Back to Trials Stack
Trials StackClinicalTrials.gov

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Clinical trial record NCT06774079 was updated or published. See the registry for its current status, eligibility, and results (if reported).

Open original source ↗

Collected Oct 31, 2026. Third-party data may change. Consult the original publication or registry for complete methods, findings and status.